A New Approach to Mental Healthcare

Ehave is empowering the mental health community with a next generation of digital solutions to facilitate objective, data-driven decision making and personalized patient care.

About Ehave

Ehave (Ticker: EHVVF) is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis, and treatment. With Ehave Connect, Ehave’s mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems (“MHS”), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder (“ADHD”), through its collaboration with the Hospital for Sick Children (“SickKids”). Ehave Connect is also being utilized to advance the validation and optimization of medical marijuana, through its collaboration with MedReleaf. Ehave is headquartered in Toronto’s Discovery District, a hub of healthcare, innovation, and technology in Toronto, Canada.

Recent News and Insights

We Believe that a Game-Changing Technology is Long Overdue

Patients and their caregivers are often hindered by an outdated and inefficient mental healthcare delivery system – despite rapid innovation in other sectors, many practitioners rely upon diagnostic and treatment methodologies developed in the last century. We believe the mental health community is long overdue for a technology breakthrough to catapult patient care into the current era of data-driven decision making and personalized treatment.

Introducing Ehave Connect

Ehave Connect is a mental health informatics platform that efficiently captures, integrates, and delivers high-quality, objective patient data. By bridging the substantial information gap in mental healthcare, while at the same time facilitating the deployment of novel digital assessment and remediation tools, we believe that we will empower clinicians and improve patient care. Ehave Connect is also intended to benefit mental health researchers and payors, who for the first time have access to a wealth of data. Learn more >>

Ehave is initially focused on attention deficit hyperactivity disorder (“ADHD”) and the emerging medical marijuana industry.

Improved methods for diagnosing and treating ADHD

ADHD is a common childhood disorder characterized by developmentally inappropriate levels of hyperactivity, impulsivity, and inattention. ADHD is a common affliction with worldwide prevalence estimated at approximately 7%. Despite extensive advances in understanding this complex disorder, improved methods for diagnosis and treatment are desired. Learn more >>

An Evidence-Based Approach to Treatment Using Marijuana

Researchers are investigating the use of medical marijuana for the treatment of mental health conditions including post-traumatic stress disorder (“PTSD”), anxiety, and depression. While data suggests the potential for efficacy, an evidence-based approach is needed to determine whether cannabis and its components are beneficial. Learn more >>

Ehave Solutions Benefit a Variety of User Types

Ehave Connect provides a turnkey set of solutions for mental healthcare clinicians, patients, and others who can benefit from objective data-driven insights. We believe the broad applicability of Ehave Connect and the unmet need in mental healthcare positions Ehave for rapid expansion across multiple segments.


Ehave empowers mental healthcare professionals with a suite of integrated tools to better serve patients in a variety managed care and outpatient settings.


Persons receiving or in need of mental healthcare services will benefit from clinically validated digital diagnostic and treatment tools that are more accessible and transparent.


Ehave seeks to bring powerful, data-driven insights to the mental healthcare field to significantly advance academic and pharmaceutical research.

Learn More

Contact us to schedule a demo.